Shukra Pharmaceuticals Ltd.

Financial

	Shukra Pharma	Kwality Pharma	NGL Fine-Chem
Operational Metrics
Financials
5 yr Average ROE	11.12 %	25.87 %	18.84 %
5yr average Equity Multiplier	2.18	2.2	1.38
5yr Average Asset Turnover Ratio	0.6	1.09	1.06
5yr Avg Net Profit Margin	7.6 %	10.7 %	12.49 %
Price to Book	13.89	3.23	2.5
P/E	92.22	26.22	21.43
5yr Avg Cash Conversion Cycle	-20.3 Days	46.51 Days	36.59 Days
Inventory Days	31.54 Days	59.9 Days	49.75 Days
Days Receivable	133.87 Days	110.56 Days	83.78 Days
Days Payable	381.54 Days	112.27 Days	82.12 Days
5yr Average Interest Coverage Ratio	36.02	15.91	24.92
5yr Avg ROCE	10.67 %	34.24 %	25.51 %
5yr Avg Operating Profit Margin	15.03 %	20.92 %	18.8 %
5 yr average Debt to Equity	0.32	0.52	0.17
5yr CAGR Net Profit	241.36 %	23.39 %	38.35 %
5yr Average Return on Assets	6.5 %	12.43 %	13.85 %
Shareholdings
Promoter Holding	50.96 %	54.83 %	72.74 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	1.79 %	0.4 %	-1.07 %
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0

Business

	Shukra Pharma	Kwality Pharma	NGL Fine-Chem
Product Wise Break-Up	Product Wise Break-Up Intermediates 0 Veterinary APIs 0 Human APIs 0 Finished Dosages 0 Others 100	-	Product Wise Break-Up Intermediates 1.98 Formulations 1.98 Human APIs 2.97 Veterinary APIs 93.07